MID-STEP Trial
Cross-source consensus on MID-STEP Trial from 1 sources and 5 claims.
1 sources · 5 claims
Comparisons
Other
Other
Other
Other
Highlighted claims
- Patients in MID-STEP are allocated equally to midodrine plus standard care or standard care alone. — Midodrine for Sepsis Treatment and Early Vasopressor Weaning (MID-STEP): protocol for a pragmatic randomised clinical trial
- MID-STEP is a pragmatic, open-label, randomized, parallel-group superiority trial. — Midodrine for Sepsis Treatment and Early Vasopressor Weaning (MID-STEP): protocol for a pragmatic randomised clinical trial
- The trial is registered on ClinicalTrials.gov and was approved by the Mayo Clinic IRB. — Midodrine for Sepsis Treatment and Early Vasopressor Weaning (MID-STEP): protocol for a pragmatic randomised clinical trial
- MID-STEP is expected to be completed in March 2029. — Midodrine for Sepsis Treatment and Early Vasopressor Weaning (MID-STEP): protocol for a pragmatic randomised clinical trial
- The trial spans six Mayo Clinic hospitals across four states to improve generalizability. — Midodrine for Sepsis Treatment and Early Vasopressor Weaning (MID-STEP): protocol for a pragmatic randomised clinical trial